智通财经APP获悉，博安生物(06955)今早一度跌超20%，盘中触及2.7港元创上市以来新低。截至发稿，跌12.7%，报2.99港元，成交额1031.75万港元。
消息面上，据沪深交易所公告，博安生物被调出港股通标的证券名单，并自今日（9月7日）起正式生效。调出后，港股通投资者将只能卖出、无法再买入。值得注意的是，截至9月4日，南向资金持有博安生物约1.456亿股，持股占比约23.39%。
今年上半年，博安生物实现收入2.33亿元人民币，同比减少约40.8%，收入减少主要是由于即将实施的政府主导集中采购的政策预期；期内母公司拥有人应占亏损8300.9万元，去年同期溢利2051.4万元，同比由盈转亏。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.